Theragenics

Risk score

60
Manufacturer

Headquarters

Flag of United States of AmericaUnited States of America

Theragenics was established in 1981 and swiftly emerged as a global frontrunner in the production of radioactive brachytherapy seeds for the management of localized prostate cancer. In 2005, we initiated diversification of our operations through the acquisition of CP Medical, Inc., and have since continued to broaden our horizons with the procurement of Galt Medical Corp., NeedleTech Products, Inc., Concert Medical, and Arrotek.

Products & Services

Bulk Indium Chloride In-111 Radiochemical

Gallium chloride

Gallium Chloride Ga-67 Bulk Radiochemical

Indium trichloride